搜索临床试验以:PD-1 Antibody
总计53329个结果
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.完全的
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.完全的
-
Merck Sharp & Dohme LLC招聘中非小细胞肺癌 | 实体瘤 | 程序性细胞死亡-1(PD1、PD-1) | 程序性细胞死亡 1 配体 1(PDL1, PD-L1) | 程序性细胞死亡 1 配体 2(PDL2、PD-L2)日本
-
Shanghai International Medical Center未知
-
Agenus Inc.完全的
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Nanfang Hospital of Southern Medical University 和其他合作者招聘中
-
Shandong New Time Pharmaceutical Co., LTD尚未招聘
-
Lei Li招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Affiliated Cancer Hospital of Shantou University... 和其他合作者招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Shanghai Ninth People's Hospital Affiliated to...尚未招聘
-
Lei Li招聘中
-
The First Hospital of Jilin University主动,不招人
-
The Affiliated Hospital of Qingdao University未知
-
Centre Leon BerardNETRIS Pharma招聘中
-
Shandong New Time Pharmaceutical Co., LTD尚未招聘RR DLBCL; PD-1; CD20
-
Shanghai Zhongshan Hospital主动,不招人
-
Merck Sharp & Dohme LLC主动,不招人癌,鳞状细胞,非小细胞肺癌波兰, 大韩民国, 美国, 阿根廷, 澳大利亚, 奥地利, 巴西, 加拿大, 法国, 德国, 日本, 墨西哥, 新西兰, 罗马尼亚, 俄罗斯联邦, 西班牙, 台湾, 火鸡, 乌克兰, 英国
-
University of Colorado, DenverNational Cancer Institute (NCI); Cancer League of Colorado撤销
-
Sichuan Cancer Hospital and Research Institute尚未招聘
-
Shanghai Junshi Bioscience Co., Ltd.主动,不招人
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.尚未招聘
-
National Cancer Institute (NCI)撤销复发性经典霍奇金淋巴瘤 | 难治性经典霍奇金淋巴瘤
-
Instituto Nacional de Cancerologia de Mexico未知
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI)招聘中难治性 MSI - H 实体瘤 PD-(L) 1 治疗之前 | MSI-H 肿瘤美国
-
The First Affiliated Hospital of Guangdong Pharmaceutical...University of Technology, Sydney; Guangzhou Anjie Biomedical Technology Co., Ltd.未知
-
Capital Medical UniversityDuke University; Geneplus-Beijing Co. Ltd.完全的